Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A1 | P18405 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.33 |
| ▸ | UBE2M | P61081 | 1/20 | 0.31 |
| ▸ | DCUN1D1 | Q96GG9 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 2/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4960134 | 0.88 | ALDH1A1 (0.37) | SRD5A1ALDH1A1ALOX15L3MBTL1LMNA | |
| SCHEMBL272291 | 0.82 | KDM4C (0.37) | SRD5A1ALDH1A1ALOX15 | |
| SCHEMBL272810 | 0.82 | KDM4C (0.37) | SRD5A1ALDH1A1ALOX15 | |
| SCHEMBL8459911 | 0.82 | SRD5A1 (0.38) | SRD5A1ALDH1A1L3MBTL1THRBLMNA | |
| SCHEMBL4417247 | 0.79 | L3MBTL1 (0.35) | SRD5A1ALDH1A1ALOX15L3MBTL1THRB | |
| SCHEMBL11140293 | 0.79 | SRD5A1 (0.34) | SRD5A1L3MBTL1THRBUBE2MDCUN1D1 | |
| SCHEMBL14224276 | 0.78 | SRD5A1 (0.34) | SRD5A1THRB | |
| SCHEMBL1138443 | 0.78 | SRD5A1 (0.34) | SRD5A1THRB | |
| SCHEMBL9400312 | 0.77 | TSHR (0.37) | SRD5A1ALDH1A1THRBGAA | |
| SCHEMBL1138617 | 0.77 | L3MBTL1 (0.34) | SRD5A1ALDH1A1L3MBTL1THRBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1095006-A1 | DERIVATIVES OF 1-OXYL-4-HYDROXY-OR 4-AMINO-2,2,6,6-TETRAMETHYLPIPERIDINE AS POLYMERIZATION INHIBITORS FOR (METH) ACRYLATE MONOMERS | Ciba SC Holding AG (CH) | 2001-05-02 | — | — | EP | claimed |
| WO-2000003965-A1 | DERIVATIVES OF 1-OXYL-4-HYDROXY- OR 4-AMINO-2,2,6,6-TETRAMETHYLPIPERIDINE AS POLYMERIZATION INHIBITORS FOR (METH)ACRYLATE MONOMERS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2000-01-27 | — | — | WO | claimed |
| US-5928558-A | STORAGE STABILITY | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1999-07-27 | — | — | US | claimed |
| US-8134009-B2 | Process for the oxidation of secondary amines into the corresponding nitroxides | BASF SE (DE) | 2012-03-13 | — | — | US | disclosed |
| US-20100305322-A1 | Process for the Oxidation of Secondary Amines into the Corresponding Nitroxides | CIBA SPECIALTY CHEMICALS CORPORATION | 2010-12-02 | — | — | US | disclosed |
| EP-2030963-A2 | Derivatives of 1-oxyl-4-hydroxy-or 4-amino-2,2,6,6-tetramethylpiperidine as polymerization inhibitors for (meth) acrylate monomers | Ciba Holding Inc. (CH) | 2009-03-04 | — | — | EP | disclosed |
| EP-1095006-A1 | DERIVATIVES OF 1-OXYL-4-HYDROXY-OR 4-AMINO-2,2,6,6-TETRAMETHYLPIPERIDINE AS POLYMERIZATION INHIBITORS FOR (METH) ACRYLATE MONOMERS | Ciba SC Holding AG (CH) | 2001-05-02 | — | — | EP | disclosed |
| EP-1000032-A1 | INHIBITION OF PULP AND PAPER YELLOWING USING NITROXIDES AND OTHER COADDITIVES | Ciba SC Holding AG (CH) | 2000-05-17 | — | — | EP | disclosed |
| WO-2000003965-A1 | DERIVATIVES OF 1-OXYL-4-HYDROXY- OR 4-AMINO-2,2,6,6-TETRAMETHYLPIPERIDINE AS POLYMERIZATION INHIBITORS FOR (METH)ACRYLATE MONOMERS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2000-01-27 | — | — | WO | disclosed |
| US-5928558-A | STORAGE STABILITY | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1999-07-27 | — | — | US | disclosed |
| WO-1999005108-A1 | INHIBITION OF PULP AND PAPER YELLOWING USING NITROXIDES AND OTHER COADDITIVES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1999-02-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100305322-A1 | Process for the Oxidation of Secondary Amines into the Corresponding Nitroxides | NOS2, NOS1, NOS3 | SRD5A1 1821/4885ALDH1A1 1179/4885ALOX15 797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.